Navigation Links
Somanta Announces the Presentation of Alchemix Data at The American,Association for Cancer Research Annual Meeting

IRVINE, Calif. and LONDON--(BUSINESS WIRE)--Apr 16, 2007 - Somanta Pharmaceuticals (OTCBB:SMPM) today announced that data from its Alchemix program will be presented later today at the American Association for Cancer Research Annual Meeting in Los Angeles.

The poster presentation is entitled "Cytotoxicity of novel alkylating anthraquinones in cells with DNA Nucleotide Excision Repair and DNA Mismatch Repair defects," and focuses on structure-activity studies on the company's novel technology for targeting and irreversibly binding to DNA / DNA processing enzymes. The studies reported in the poster were conducted at the Institute for Cancer Therapeutics at the University of Bradford, Bradford, United Kingdom (www.cancer.Brad.ac.uk) under the collaborative research agreement announced previously.

Somanata recently announced the company had signed a letter of intent to be acquired by Access Pharmaceuticals, Inc, (OTCBB:ACCP) an emerging oncology-focused biopharmaceutical company based in Dallas, Texas.

About Somanta Pharmaceuticals

Somanta Pharmaceuticals, Inc. ("Somanta") is a specialty oncology company with particular focus on in-licensing anti-cancer agents with substantial clinical data supporting safety and efficacy. To date, the Company has successfully in-licensed the rights to four products, each with a different mode of action and targeting eleven different cancer types.

Certain statements contained herein are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Because these statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Specifically, factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statem
'"/>




Page: 1 2

Related medicine technology :

1. Access and Somanta Announce Data to be Presented on Angiolix at ASCO Oncology Conference
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:5/23/2013)... , May 23, 2013  Hadasit Bio-Holdings Ltd. ... of biotech companies, based on intellectual property developed ... Israel ,s foremost medical research center, today ... Ltd., received significant funding from the Israeli Ministry ... Scientist (OCS) to support product development and advance ...
(Date:5/23/2013)... 2013 Anthem Blue Cross patients with HIV/AIDS ... them to obtain their medications by mail order under ... Kallas LLC.  The lawsuit, filed in ... Cross,s mandatory mail order program announced late last year ... "This settlement brings to a close a ...
(Date:5/23/2013)... Mass. , May 23, 2013  Hologic, ... HOLX ), a leading developer, manufacturer and supplier ... products, with an emphasis on serving the healthcare ... large-scale observational study in a U.S. clinical practice ... technology (breast tomosynthesis) with conventional 2D mammography alone ...
Breaking Medicine Technology:Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
... 29 FUJIFILM Medical Systems USA, Inc. is pleased to ... at the 2009 Radiological Society of North America (RSNA) Annual ... an innovative new technology to provide clinicians with Fujifilm,s trademark ... a smart way for users to transition to DR without ...
... Nov. 28 Siemens Healthcare redefines productivity with a ... technology and with its new Dot(TM) (Day optimizing throughput) engine. ... Aera* 1.5 Tesla (T) and the new MAGNETOM Skyra* 3T ... the Radiological Society of North America (RSNA) from November 29 ...
Cached Medicine Technology:FUJIFILM's DR Cassette Makes World Debut 2Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7
(Date:5/25/2013)... California (PRWEB) May 25, 2013 According to ... titled “Hooked on a Feeling,” nearly 30 million Americans tan ... to tan despite knowing the health risks. ... seductive and even addictive effect on the brains of some ... included in the article so I can’t say that I ...
(Date:5/25/2013)... Newport Beach, California (PRWEB) May 25, 2013 ... weekend respectfully honoring those who have died serving our ... from work with prolonged partying and recklessness. The DUI ... Memorial Day Weekend DUI checklist to help keep this ... California’s Traffic Records System , there were more than ...
(Date:5/25/2013)... 25, 2013 Dr. Leslie Gerstman ... FDA-approved to lift skin on the neck, on the brow ... practice, Medical Aesthetics. , Ultherapy is a non-surgical procedure for ... healing process to lift the skin over time. The use ... to see and then treat the deepest support layers of ...
(Date:5/25/2013)... 25, 2013 Life science and analytical ... to detect and create a new substance with the ... are also known as biotechnology reagents. Such reagents are ... education. , This market is driven by factors such ... field of therapeutics, growth in research and rapid commercialization ...
(Date:5/25/2013)... Boise, Idaho (PRWEB) May 25, 2013 ... most prevalent type of peripheral neuropathy. According to neuropathy ... http://goo.gl/aLMtn , it is estimated that the disorder affects ... most common complication arising from Diabetes. The high blood ... of Diabetes and patients suffering from it usually tend ...
Breaking Medicine News(10 mins):Health News:Sun Damage – Are UV Rays Addictive? 2Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 2Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 3Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2
... Company Gifts of over $50 to,Doctors, ALBANY, ... Assembly Health Committee reported key legislation (see vote ... and sold in New York,State. Governor Paterson,s bill, ... ban on gifts of over $50 to doctors ...
... More than two million free antibiotic prescriptions ... Supercenter retailer Meijer,has announced plans to offer free ... The announcement was made today by Nat Love,Vice President ... "As a family-focused company, offering free pre-natal vitamins ...
... Rally Residents to Eat Right, Move More and Milk ... Their ... by,the ups and downs of different fad diets -- which seem to go ... been,slim. Two out of three Americans -- including 51 percent of Boise residents,-- ...
... State officials desire quick-response emergency capability to treat ... suspected and known cyanide ... L.P. today announced that the,Florida Department of Health, Office ... ANTIDOTE for Cyanide,Poisoning in the State,s emergency medical service ...
... age and ethnicity has a significant impact on overall ... led by researchers at the University of Southern California ... , While age and ethnicity are well-established factors that ... gender also plays an important role in overall survival, ...
... makes ovaries lose their ability to produce estrogens and ... this stage, when menstruation cesses, there appear physical and ... articulation and bone pain, headaches, insomnia, sadness, depression and ... the average age for the cessation of the menstrual ...
Cached Medicine News:Health News:Assembly on the Move for Rx Reform 2Health News:Assembly on the Move for Rx Reform 3Health News:Meijer Pharmacies to Offer Free Pre-Natal Vitamins 2Health News:Message to Idaho Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Idaho Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Florida EMS and Fire Vehicles to Stock Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE ("Cyanokit") for Cyanide Poisoning 2Health News:Florida EMS and Fire Vehicles to Stock Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE ("Cyanokit") for Cyanide Poisoning 3Health News:USC study finds sex, age and ethnicity assciated with colorectal cancer survival 2Health News:Post-menopausal therapy to improve women's quality of life 2
... Proteomeworks system is an integrated ... that enables protein function discovery. ... preparation, 2-D electrophoresis, staining, imaging ... automated protein digestion, mass spectrometry, ...
Storage temperature: 2 - 8C, linearity: 0 - 700 mg/dL, expected values: 30 - 780 mg/dL. Available with calibrator and number of tests 110....
Alkaline phosphatase FS (IFCC). For determination of alkaline phosphatase (ALP) in serum or plasma. For Hitachi 717. Controls: Trulab N and Trulab P....
For the quantitative determination of Alkaline Phosphatase in serum. Linearity: 800 IU/L at 37C. P-nitrophenyl phosphate substrate....
Medicine Products: